This is a very uncertain time for all of us. We are working closely with our partner organization, the Canadian Skin Patient Alliance (CSPA) and medical and scientific experts to answer your questions and help provide you with up-to-date information about how to stay healthy. Please visit canadianskin.ca/education/covid-19 for information about the risks and impacts of COVID-19. That page will be updated regularly and new Q&As shared on CSPA’s and CAPP’s social media. If you have any questions that you would like answered, please let us know at or on their social channels.
Psoriasis and Covid-19 Registry
The Canadian Association of Psoriasis Patients is partnering with other patient and healthcare provider organizations around the world on PsoPROTECT, a registry of psoriasis and psoriatic arthritis patients who have COVID-19.
PsoPROTECT seeks to rapidly improve our understanding of how factors such as immunomodulator therapies and comorbidities impact outcomes to COVID-19 in psoriasis. This information will inform clinicians when assessing risk and treating COVID-19 in patients with psoriasis.
Dermatologists, rheumatologists and other healthcare providers can fill out a short form to report cases of COVID-19 in psoriasis patients using the online PsoPROTECT case report form. This form collects de-identified data and takes approximately 5 minutes to complete. Your healthcare provider will be provided with a copy of your completed report form once it is submitted.
The PsoPROTECT registry will provide regular, open access summaries of all reported cases for the benefit of the international psoriasis community.
We are happy to share these links to COVID-19 resource pages from other patient organizations.